A new summer COVID wave may be on its way
Why it matters: The data suggests another summer of illness could be in the offing as people get more people lose protection from vaccination, natural immunity wanes and the virus keeps mutating.
A CDC report posted last week shows COVID circulation in the U.S. has had two consistent annual peaks — in late summer and winter — since 2020.
What they're saying: COVID-19 cases are growing in 25 states, including Florida, Texas, California and Ohio, per the CDC. They're likely growing in more than a dozen others.
COVID-19 activity detected through wastewater surveillance and emergency department visits for COVID-19 remain low across the country, while influenza and RSV visits are "very low."
What to watch: The most dominant COVID variant circulating in the U.S. is NB.1.8.1, nicknamed "nimbus", per the CDC.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Hill
7 minutes ago
- The Hill
Legionnaires' outbreak grows: What are the disease's first symptoms?
(NEXSTAR) – Three people have died and at least 67 have been infected as a cluster of Legionnaires' disease cases in New York City continues to spread. The case count has ballooned since the bacteria that causes Legionnaires' started sickening people in late July. City health officials link the outbreak in Central Harlem to cooling towers, structures containing water and a fan that are used to cool buildings. They said 11 of these towers initially tested positive for a type of bacteria that causes Legionnaires', but the problem has been fixed. Three dead as Legionnaires' cluster spreads in NYC Legionnaires' disease is a type of pneumonia caused by bacteria that grows in warm water. It can spread through water systems, like showerheads, hot tubs or cooling towers for central AC. People often get the disease by inhaling mist from contaminated water, but it is not spread from person to person. What are the symptoms of Legionnaires' disease? Once exposed to the bacteria, symptoms can take anywhere from two days to two weeks to show up, according to the Centers for Disease Control and Prevention. The symptoms of Legionnaires' overlap with other pneumonia symptoms: cough, fever, headaches, muscle aches and shortness of breath. In the most serious cases, Legionnaires' can cause lung failure or death. The pneumonia can be confirmed with a chest X-ray, but a lab test of a patient's urine or phlegm would be able to confirm if the pneumonia is caused by Legionella bacteria. Most people exposed to the bacteria don't get sick, the CDC notes, but those with pre-existing conditions can suffer serious symptoms or death. About 1 in 10 people who gets the disease will die due to complications, the CDC says. What is the treatment for Legionnaires' disease? Those in the neighborhoods of New York City impacted by the outbreak (ZIP codes 10027, 10030, 10035, 10037, 10039 and surrounding areas) should contact their doctor if they have any of the symptoms described above. That's especially true for people 50 and older, people who smoke and people with chronic lung conditions, as they are more susceptible to serious consequences. Once identified, the disease can be treated with antibiotics.
New York Post
7 minutes ago
- New York Post
Are mRNA vaccines safe and effective? What to know as RFK Jr. halts funding
Vaccines using mRNA technology weren't immune to the latest round of federal research cuts. Health and Human Services Secretary Robert F. Kennedy Jr. said this week that he's pulling the plug on nearly $500 million in funding for the development of mRNA vaccines. The 22 projects are managed by the Biomedical Advanced Research and Development Authority (BARDA). 'The data show these vaccines fail to protect effectively against upper respiratory infections like COVID and flu,' Kennedy, a longtime vaccine critic, said in a statement. 'We're shifting that funding toward safer, broader vaccine platforms that remain effective even as viruses mutate.' 4 Health and Human Services Secretary Robert F. Kennedy Jr. said this week that he's pulling the plug on nearly $500 million in funding for the development of mRNA vaccines. AP Several studies have demonstrated that mRNA COVID-19 vaccines were over 90% effective at preventing severe illness and death. Vaccine researchers immediately took issue with the fiscal gutting, calling it a major setback for science. 'I don't think I've seen a more dangerous decision in public health in my 50 years in the business,' said Mike Osterholm, a University of Minnesota expert on infectious diseases and pandemic preparations. Here's a closer look at how mRNA vaccines work. What is mRNA? All living cells have ribonucleic acid, an essential biological molecule known as RNA. RNA's primary role in the body is to make proteins, which are needed for virtually every cellular process, from building and repairing tissues to defending the body from bacteria and viruses and transporting nutrients and oxygen. 4 The COVID-19 vaccine manufactured by Pfizer and Biontec is administered during a clinical trial. EPA/Biontech SE/Handout Proteins are synthesized using three main types of RNA — messenger RNA (mRNA), transfer RNA (tRNA) and ribosomal RNA (rRNA). MRNA's job is to carry information for protein making from DNA to the cell's ribosomes, where it's translated into proteins. How do mRNA vaccines work? MRNA can be created in a laboratory and injected into the body to instruct cells to make a protein associated with a specific virus. The body recognizes the protein as foreign and produces antibodies to combat it. When the actual virus or pathogen invades the body, the immune system is ready to neutralize it, preventing or reducing the severity of illness. Though mRNA was discovered in the early 1960s, the first mRNA vaccine wasn't approved for human use until 2020. 4 German firm BioNTech, Pfizer's partner on its Covid vaccine, is developing mRNA-based vaccines for cancers at a rapid pace. Photothek via Getty Images The US Food and Drug Administration (FDA) authorized Pfizer's COVID-19 vaccine for emergency use in December 2020 and later granted full approval. The vaccine uses mRNA to tell cells to make a harmless piece of the coronavirus's spike protein. Moderna's COVID-19 vaccine was also granted full approval by the FDA. MRNA vaccines are being explored for the treatment of cancer, food allergies and infectious diseases. Researchers say that mRNA vaccines can be developed faster than traditional vaccines because they do not require the time-consuming process of growing live virus cultures in a lab. 'The theoretical advantage of mRNA-based vaccines lies in their rapid adaptability,' Grant Hansman, senior research fellow at the Institute for Biomedicine and Glycomics at Griffith University in Australia, wrote this week in The Conversation. 'They will potentially allow annual updates to match circulating strains.' 4 University College London Hospital (UCLH) in London is testing novel cancer immunotherapy that aims to prevent skin cancer from recurring. The mRNA-based technology is for people who have already had high-risk melanomas removed. PA Images via Getty Images The Centers for Disease Control and Prevention notes that mRNA vaccines do not contain any live viruses or pathogens and do not alter a person's DNA. The mRNA molecule eventually breaks down in the body. The Cleveland Clinic reports that the risks of mRNA vaccines include pain or swelling at the injection site, fever, fatigue, headaches, muscle aches and allergic reactions. In his statement, Kennedy said that mRNA vaccines will be phased out in favor of whole killed virus vaccines, a traditional approach that uses entire pathogens that have been inactivated through heat, radiation or chemicals. Though it's a tried-and-true method of immunization, critics have raised concerns that these vaccines produce a weaker immune response than mRNA vaccines and pose manufacturing and logistical challenges. With Post wires
8 minutes ago
RFK Jr. cancels $550 million in funding for MRNA vaccine development
Robert F. Kennedy Jr. announced that the Department of Health and Human Services will cancel $500 million in funding for MRNA vaccines for viruses like COVID-19 and the flu. August 6, 2025
